NCT04615000 is a clinical trial of SARS-CoV-2 serological assessment (IgG) in Covid19, sponsored by University Hospital, Ghent.

Who is sponsoring NCT04615000?

NCT04615000 is sponsored by University Hospital, Ghent.

What drugs are being tested in NCT04615000?

Interventions in NCT04615000: SARS-CoV-2 serological assessment (IgG).

What condition does NCT04615000 study?

NCT04615000 studies Covid19, Children, Only.

Is NCT04615000 still recruiting?

NCT04615000 is currently completed. Last updated 1 July 2022.

Last reviewed 2022-07-01 · How we verify

NCT04615000

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SeroCovid<19: Covid-19 Seroconversion in Tertiary Pediatric Patients

Completed Last updated 1 July 2022

What this trial tests

trial testing SARS-CoV-2 serological assessment (IgG) in Covid19 in 362 participants. Completed in 1 November 2021.

Timeline

29 October 2020

Primary endpoint
1 November 2021

1 November 2021

Quick facts

Lead sponsor	University Hospital, Ghent
Status	Completed
Study type	OBSERVATIONAL
Enrollment	362
Start date	29 October 2020
Primary completion	1 November 2021
Estimated completion	1 November 2021
Sites	1 location across Belgium

Drugs / interventions tested

SARS-CoV-2 serological assessment (IgG)

Conditions studied

Covid19 — all drugs for Covid19 →
Children, Only — all drugs for Children, Only →

Sponsor

University Hospital, Ghent

Who can join

Under 18, any sex, with Covid19 or Children, Only. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Children are relatively spared from the direct clinical impact of COVID-19. Pediatric patients with regular follow-up at tertiary pediatric centres and presenting one or more chronic conditions might be at increased risk for severe COVID-19. With a prospective seroprevalence study, we aim to study COVID-19 incidence, disease course and risk factors associated with SARS-CoV-2 infection in this specific context.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of SARS-CoV-2 seroconversion in children with chronic diseases with healthy children and adults during the first waves of the COVID-19 pandemic.
Hoste L, Prytula A, Dehoorne J, De Bruyne R, et al · · 2023 · cited 1× · PMID 37609364 · DOI 10.3389/fped.2023.1210181

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other University Hospital, Ghent trials

Trials by the same sponsor.

NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04615000 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
Last refreshed: 1 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04615000.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing